NDTV Profit-Latest Aurobindo Pharma Recalls Products In US Market For Manufacturing Lapses By चन्द्र कुमार अधिकारी Tuesday, November 8, 2022 Comment Aurobindo Pharma units are recalling different products in the US market for manufacturing lapses, as per the US health regulator. from NDTV Profit-Latest https://ift.tt/rPNqzRX Related PostsBudget 2023 - Centre To Focus On Gradual Fiscal Consolidation: ReportCentre May Moderate Divestment Target For Fiscal 2024: ReportGoMechanic Sacks 70% WorkforcePhonePe Raises $350 Million At $12 Billion Valuation
0 Response to "Aurobindo Pharma Recalls Products In US Market For Manufacturing Lapses"
Post a Comment